allcancercure.com

Chemotherapy with fluorouracil and folinic acid could improve survival of patients with stage II colorectal cancer compared with observation alone, although the absolute improvements are small. These are the conclusions of an Article in this week’s edition of The Lancet. Colorectal cancer is the second most common malignant disease in developed countries, with 1 million [...]

Only half of all Americans age 50 and over have had a colonoscopy, one of several common screening tests for colon cancer, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The U.S. Preventive Services Task Force recommends that all people age 50 and over be screened for colon [...]

Damaged or defective genes have long been known to be the cause of some cancers. Over the past decade, however, scientists have discovered that even healthy genes can be switched on or off and can cause cancer without any changes in the underlying DNA sequence – although how this happens has remained poorly understood. Researchers [...]

Some minority populations in the United States are so isolated from mainstream cancer awareness efforts, they seem like separate nations unto themselves – a literal distinction for Navajo Indians. In the first-ever assessment of cancer awareness among members of the Navajo Nation, researchers at the University of Arizona Cancer Center have determined that cancer education [...]

Findings from a new report published in the Journal of Clinical Oncology suggest that Erbitux® (cetuximab) in combination with chemotherapy provides pretreated, unresectable patients who have liver metastases with the possibility of cure for their metastatic colorectal cancer (mCRC).1 These findings demonstrate that pretreated mCRC patients who were previously unresectable can become resectable. “The results [...]

Immunicon Corporation (NASDAQ-GM:IMMC) announced that FDA clearance has been received for the CellSearch™ Circulating Tumor Cell Kit as an aid in the monitoring of patients with metastatic colorectal cancer. The CellSearch test was originally cleared in 2004 for in vitro diagnostic use in patients with metastatic breast cancer. Serial testing for circulating tumor cell (CTC) [...]

Immunicon Corporation (NASDAQ-GM:IMMC) announced that FDA clearance has been received for the CellSearch™ Circulating Tumor Cell Kit as an aid in the monitoring of patients with metastatic colorectal cancer. The CellSearch test was originally cleared in 2004 for in vitro diagnostic use in patients with metastatic breast cancer. Serial testing for circulating tumor cell (CTC) [...]

Veridex, LLC announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch™ System to be used as an aid in the monitoring of metastatic colorectal cancer. CellSearch™ is currently approved for monitoring metastatic breast cancer. The CellSearch™ System identifies and counts circulating tumor cells (CTCs) in a blood [...]

National charity Bowel Cancer UK launches a comprehensive report into the progress of the NHS National Bowel Cancer Screening Programme in England, which rolled out fifteen months ago. The report also sets out the charity’s recommendations for the future of screening, to ensure that the Programme’s positive impact on people’s lives continues. The report makes [...]

CT colonography (CTC), when used in elderly patients, can detect a high number of new and significant abnormalities outside the colon (including cirrhosis and tumors) and is well tolerated, according to a recent study conducted by researchers at St. James’s University Hospital in Leeds, United Kingdom (UK). “We decided to target older patients (over age [...]